These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recent progress in the battle between oncolytic viruses and tumours. Parato KA; Senger D; Forsyth PA; Bell JC Nat Rev Cancer; 2005 Dec; 5(12):965-76. PubMed ID: 16294217 [TBL] [Abstract][Full Text] [Related]
7. To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control. Mohr I Oncogene; 2005 Nov; 24(52):7697-709. PubMed ID: 16299530 [TBL] [Abstract][Full Text] [Related]
8. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Sinkovics JG; Horvath JC Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757 [TBL] [Abstract][Full Text] [Related]
16. A demand for next-generation oncolytic adenoviruses. Hermiston T Curr Opin Mol Ther; 2006 Aug; 8(4):322-30. PubMed ID: 16955695 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy progress and prospects cancer: oncolytic viruses. Liu TC; Kirn D Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413 [TBL] [Abstract][Full Text] [Related]
18. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533 [TBL] [Abstract][Full Text] [Related]